Meeting
2020 ASCO Virtual Scientific Program
Risk of venous thromboembolism in patients receiving neoadjuvant chemotherapy for ovarian cancer.
Authors
Derman Basaran
Memorial Sloan Kettering Cancer Center, New York, NY
Derman Basaran , Jessa Suhner , Dib Sassine , Thomas Boerner , Ying L Liu , Rachel N. Grisham , William P. Tew , Ginger J. Gardner , Oliver Zivanovic , Yukio Sonoda , Kara C. Long-Roche , Dennis Chi , Gerald A. Soff , Elizabeth Lin Jewell
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gynecologic Cancer
Track
Gynecologic Cancer
Sub Track
Ovarian Cancer
Citation
J Clin Oncol 38: 2020 (suppl; abstr 6073)
DOI
10.1200/JCO.2020.38.15_suppl.6073
Abstract #
6073
Poster Bd #
244
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Venous thromboembolism prophylaxis during neoadjuvant chemotherapy for patients with ovarian cancer.
First Author: Hannah Dysinger McLaughlin
Poster
2023 ASCO Annual Meeting
CD47 expression in ovarian cancer: Dynamic correlation with lymphocyte and macrophage features as well as thrombospondin-1 (TSP-1) under neoadjuvant chemotherapy.
First Author: Alexandra Leary
Poster
2023 ASCO Annual Meeting
Utility of surgically documented minimal residual disease as a therapeutic target and early surrogate of frontline treatment outcomes in ovarian cancer.
First Author: Anne Knisely
Poster
2023 ASCO Annual Meeting
The role of Chemotherapy Response Score (CRS) in the decision making process for advanced high grade serous ovarian cancer patients undergoing neoadjuvant chemotherapy.
First Author: Claudia Marchetti